Rachel Capone, MSHS
Advertisement
Rachel Capone, MSHS, is a regulatory affairs manager, Syner-G BioPharma Group.
Articles by Rachel Capone, MSHS
Advertisement
Latest Updated Articles
Unlocking the Benefits of FDA’s Orphan Drug DesignationPublished: August 22nd 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
House Republicans Block Vote on ACA Subsidy Extension
2
Zasocitinib Hits Phase 3 End Points in Plaque Psoriasis
3
FDA Approval of Subcutaneous Amivantamab Offers Faster, Safer Option for EGFR-Mutated NSCLC
4
ICYMI: Highlights From the 2025 ASPC Congress on CVD Prevention
5
